Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 826 across all filing types
Latest filing 2013-11-08 Declaration of Voting R…
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it provides information regarding the 'nombre d'actions et de droits de vote' (number of shares and voting rights) as of a specific date (October 31, 2013), referencing French commercial code (Article L.233-8 II du Code de Commerce) and AMF regulations (article 223-16 du Règlement Général de l'Autorité des Marchés Financiers). This type of regular disclosure detailing the total number of shares and voting rights is typically classified as a regulatory filing or a specific announcement related to capital structure/voting rights. Since the provided definitions do not have a specific code for 'Total Shares and Voting Rights Disclosure', I must evaluate the closest fits. It is not an AGM-R, 10-K, ER, or IR. It is a formal regulatory disclosure about the capital base and voting power. This fits best under 'Regulatory Filings' (RNS) as a general regulatory announcement, or potentially 'Share Issue/Capital Change' (SHA) if interpreted broadly, but RNS is the safer fallback for specific, non-standard regulatory reports. Given the context of mandatory periodic disclosure of voting rights, RNS is the most appropriate general regulatory category.
2013-11-08 French
Quarterly financial report / Third quarter financial report
Earnings Release Classification · 1% confidence The document is explicitly titled '# Press Release' and begins by announcing 'revenues of EUR 4.7 M for the third quarter of 2013'. It presents key financial figures (revenues, cash position) for a specific period (Q3 2013 and nine months ended Sept 30, 2013) in a summarized format, typical of an initial results announcement, rather than a comprehensive annual report (10-K) or a detailed interim report (IR). The content focuses on the highlights and immediate financial performance summary. This aligns perfectly with the definition of an Earnings Release (ER). The document length (8195 chars) is substantial but the format is that of a press release summarizing results, not a full regulatory filing. Q3 2013
2013-10-23 English
Information financière du troisième trimestre
Earnings Release Classification · 1% confidence The document is titled "Communiqué de Presse" (Press Release) and explicitly announces the company's revenue for the third quarter of 2013 ("chiffre d'affaires du troisième trimestre"). It provides key financial highlights, including revenue tables and cash position updates, but it is not the comprehensive, audited annual report (10-K) or a detailed interim report (IR). This format, focusing on immediate financial results announcement, aligns perfectly with the definition of an Earnings Release (ER). The length (9021 chars) is substantial enough to be the release itself, not just a brief announcement of a report. Q3 2013
2013-10-23 French
Rachat d'actions / Contrat de liquidité Information relative au contrat de liquidité
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a change in the company's liquidity contract provider (DSF Markets replacing BIL Finance) following an acquisition. It details the transfer of assets related to this contract. This type of announcement, which is a specific corporate action update but not a full financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV), fits best under general regulatory announcements or specific financing/capital updates. Since it concerns a liquidity agreement, which is a form of financing/market support mechanism, it relates closely to capital structure management. However, given the options, it is a specific corporate event announcement. It is too detailed for a simple RNS fallback, but it is not a standard financial report. It is a communication about a financial arrangement/contract. The closest fit among the specific categories is 'Capital/Financing Update' (CAP) as it deals with the mechanism supporting the liquidity of its shares, or potentially 'Regulatory Filings' (RNS) if it's considered a general market announcement. Given the focus on the liquidity contract and the transfer of funds/shares related to it, 'CAP' is a strong candidate, but 'RNS' is often used for press releases detailing specific, non-standard corporate actions that don't fit elsewhere. Since it is a press release announcing a change in a financial service contract, and it is short (4271 chars), it leans towards a general regulatory announcement or a specific financing update. I will classify it as a general regulatory announcement (RNS) as it is a press release detailing a specific operational/financial agreement change, which is a common use case for RNS when a more specific code isn't available, although CAP is plausible. Re-evaluating: The core subject is the liquidity contract, which is a financing/market support tool. I will select CAP as it directly relates to capital market support mechanisms, which is a form of financing activity.
2013-10-16 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Information relative au nombre d'actions et de droits de vote en date du 30 septembre 2013' (Information relative to the number of shares and voting rights as of September 30, 2013). It explicitly cites French commercial code (Article L.233-8 II du Code de Commerce) and AMF regulations (article 223-16 du Règlement Général de l'Autorité des Marchés Financiers). The content is a table detailing the total number of shares and voting rights (BRUT and NET) for several months, culminating in the reporting date. This type of mandatory disclosure regarding the total capital structure and voting power is typically classified as a regulatory filing or a specific announcement related to share capital/voting rights. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most specific fit for reporting the total number of voting rights, although it is usually associated with the results *of* a vote. Given the context of mandatory disclosure of voting rights count, and the lack of a specific 'Share Capital Disclosure' code, this falls under general regulatory reporting. However, since it is a direct, periodic disclosure of the total voting rights count, it strongly aligns with the intent behind DVA, which covers voting rights announcements. If DVA is strictly for *results* of a vote, then RNS (Regulatory Filings) would be the fallback. Since the document is a direct disclosure of the total voting rights count, which is a key component of shareholder structure reporting, DVA is the best fit, as it relates directly to voting rights figures. The document is short and is a direct disclosure, not an announcement of a larger report.
2013-10-10 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled 'Information relative au nombre d'actions et de droits de vote en date du 31 août 2013' (Information relative to the number of shares and voting rights as of August 31, 2013). It explicitly cites French commercial code (Article L.233-8 II du Code de Commerce) and AMF regulations (article 223-16 du Règlement Général de l'Autorité des Marchés Financiers). The core content is a table detailing the total number of shares and voting rights (gross and net) for several preceding months, culminating in the specified date. This type of regular disclosure regarding the total number of shares and voting rights is a specific regulatory requirement in many jurisdictions, often related to major shareholding notifications or capital structure transparency. Given the options, this disclosure most closely aligns with reporting changes in significant share ownership or capital structure transparency, which falls under Major Shareholding Notification (MRQ) or potentially a general Regulatory Filing (RNS). Since it is a specific, recurring disclosure about the total voting rights, it is a form of major shareholding/capital structure update. However, the most precise fit among the provided codes for disclosures detailing the total number of voting rights and shares outstanding, especially when mandated by specific articles related to share capital transparency, is often grouped with major shareholding changes or general regulatory updates. Given the options, 'Major Shareholding Notification' (MRQ) is the closest fit for disclosures concerning the total number of shares and voting rights, as these figures are crucial for determining when major holdings thresholds are crossed. If MRQ is interpreted strictly as *changes* in ownership by a specific entity, and this is a periodic total, 'RNS' (Regulatory Filings) might be considered. However, in many European contexts, the periodic disclosure of total voting rights is intrinsically linked to shareholding transparency requirements. Let's re-evaluate the definitions. MRQ is 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document provides the *total* outstanding rights, which is the basis for calculating thresholds. Since it is a mandatory, periodic disclosure of capital structure metrics, and not a general announcement of a report (RPA), it is a specific regulatory filing. Given the focus on 'droits de vote' (voting rights), MRQ is the most relevant category related to shareholder structure transparency, even if it's a total count rather than a specific entity's change. If MRQ is too narrow, RNS is the fallback. Considering the specific nature of the data (shares and voting rights), MRQ is the best fit over the general RNS.
2013-09-13 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.